{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,14]],"date-time":"2026-08-14T03:03:19Z","timestamp":1786676599599,"version":"build-2736575974"},"reference-count":44,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T00:00:00Z","timestamp":1711584000000},"content-version":"am","delay-in-days":362,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","award":["R01CA133791"],"award-info":[{"award-number":["R01CA133791"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011132","name":"Rutgers University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011132","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.ejmech.2023.115302","type":"journal-article","created":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T00:22:53Z","timestamp":1679444573000},"page":"115302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Optimization of the C2 substituents on the 1,4-bis(arylsulfonamido)naphthalene-N,N\u2032-diacetic acid scaffold for better inhibition of Keap1-Nrf2 protein-protein interaction"],"prefix":"10.1016","volume":"252","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-6004-9602","authenticated-orcid":false,"given":"Dhulfiqar.Ali","family":"Abed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1719-6199","authenticated-orcid":false,"given":"Ahmed R.","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2257-0798","authenticated-orcid":false,"given":"Sumi","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0936-2019","authenticated-orcid":false,"given":"Mai-Uyen","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4082-4330","authenticated-orcid":false,"given":"Michael P.","family":"Verzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1799-5652","authenticated-orcid":false,"given":"Longqin","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2023.115302_bib1","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.apsb.2015.05.008","article-title":"Discovery of direct inhibitors of Keap1\u2013Nrf2 protein\u2013protein interaction as potential therapeutic and preventive agents","volume":"5","author":"Abed","year":"2015","journal-title":"Acta Pharm. Sin. B."},{"key":"10.1016\/j.ejmech.2023.115302_bib2","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/med.21257","article-title":"Small molecule modulators of Keap1\u2010Nrf2\u2010ARE pathway as potential preventive and therapeutic agents","volume":"32","author":"Magesh","year":"2012","journal-title":"Med. Res. Rev."},{"key":"10.1016\/j.ejmech.2023.115302_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/35041687","article-title":"Oxidants, oxidative stress and the biology of ageing","volume":"408","author":"Finkel","year":"2000","journal-title":"Nature"},{"key":"10.1016\/j.ejmech.2023.115302_bib4","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1159\/000485089","article-title":"Antioxidants maintain cellular redox homeostasis by elimination of reactive oxygen species","volume":"44","author":"He","year":"2017","journal-title":"Cell. Physiol. Biochem."},{"key":"10.1016\/j.ejmech.2023.115302_bib5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1146\/annurev-biochem-061516-045037","article-title":"Oxidative stress","volume":"86","author":"Sies","year":"2017","journal-title":"Annu. Rev. Biochem."},{"key":"10.1016\/j.ejmech.2023.115302_bib6","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1006\/bbrc.1997.6943","article-title":"An Nrf2\/small Maf heterodimer mediates the induction of phase II detoxifying enzyme genes through antioxidant response elements","volume":"236","author":"Itoh","year":"1997","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.ejmech.2023.115302_bib7","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1073\/pnas.0307301101","article-title":"Protection against electrophile and oxidant stress by induction of the phase 2 response: fate of cysteines of the Keap1 sensor modified by inducers","volume":"101","author":"Wakabayashi","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2023.115302_bib8","doi-asserted-by":"crossref","first-page":"14960","DOI":"10.1073\/pnas.93.25.14960","article-title":"Nrf1 and Nrf2 positively and c-Fos and Fra1 negatively regulate the human antioxidant response element-mediated expression of NAD(P)H:quinone oxidoreductase1 gene","volume":"93","author":"Venugopal","year":"1996","journal-title":"Proc. Natl. Acad. Sci. U. S. A"},{"key":"10.1016\/j.ejmech.2023.115302_bib9","doi-asserted-by":"crossref","first-page":"8919","DOI":"10.1074\/jbc.M309660200","article-title":"Regulation of heme oxygenase-1 expression through the phosphatidylinositol 3-kinase\/Akt pathway and the Nrf2 transcription factor in response to the antioxidant phytochemical carnosol","volume":"279","author":"Martin","year":"2004","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115302_bib10","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1042\/bst0280033","article-title":"The Nrf2 transcription factor contributes both to the basal expression of glutathione S-transferases in mouse liver and to their induction by the chemopreventive synthetic antioxidants, butylated hydroxyanisole and ethoxyquin","volume":"28","author":"Hayes","year":"2000","journal-title":"Biochem. Soc. Trans."},{"key":"10.1016\/j.ejmech.2023.115302_bib11","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1007\/s00044-020-02539-y","article-title":"Nrf2 activation through the inhibition of Keap1\u2013Nrf2 protein\u2013protein interaction","volume":"29","author":"Lee","year":"2020","journal-title":"Med. Chem. Res."},{"key":"10.1016\/j.ejmech.2023.115302_bib12","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.mrrev.2009.12.005","article-title":"Role of oxidatively induced DNA lesions in human pathogenesis","volume":"704","author":"Sedelnikova","year":"2010","journal-title":"Mutat. Res."},{"key":"10.1016\/j.ejmech.2023.115302_bib13","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.tet.2003.11.011","article-title":"Synthesis of 4- and 6-substituted nitroindoles","volume":"60","author":"Moskalev","year":"2004","journal-title":"Tetrahedron"},{"key":"10.1016\/j.ejmech.2023.115302_bib14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1134\/S0006297911040031","article-title":"Mechanism of the Nrf2\/Keap1\/ARE signaling system","volume":"76","author":"Tkachev","year":"2011","journal-title":"Biochemistry (Mosc.)"},{"key":"10.1016\/j.ejmech.2023.115302_bib15","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1016\/j.freeradbiomed.2004.02.075","article-title":"Molecular mechanism activating Nrf2-Keap1 pathway in regulation of adaptive response to electrophiles","volume":"36","author":"Itoh","year":"2004","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ejmech.2023.115302_bib16","first-page":"139","article-title":"An important role of Nrf2-ARE pathway in the cellular defense mechanism","volume":"37","author":"Lee","year":"2004","journal-title":"J. Biochem. Mol. Biol."},{"key":"10.1016\/j.ejmech.2023.115302_bib17","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1093\/mutage\/geh025","article-title":"Endogenous DNA damage in humans: a review of quantitative data","volume":"19","author":"De Bont","year":"2004","journal-title":"Mutagenesis"},{"key":"10.1016\/j.ejmech.2023.115302_bib18","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.abb.2016.08.005","article-title":"Keap1, the cysteine-based mammalian intracellular sensor for electrophiles and oxidants","volume":"617","author":"Dinkova-Kostova","year":"2017","journal-title":"Arch. Biochem. Biophys."},{"key":"10.1016\/j.ejmech.2023.115302_bib19","doi-asserted-by":"crossref","first-page":"16817","DOI":"10.1074\/jbc.R117.800169","article-title":"Stress-sensing mechanisms and the physiological roles of the Keap1\u2013Nrf2 system during cellular stress","volume":"292","author":"Suzuki","year":"2017","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejmech.2023.115302_bib20","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.ejmech.2015.08.049","article-title":"Probing the structural requirements of non-electrophilic naphthalene-based Nrf2 activators","volume":"103","author":"Jain","year":"2015","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115302_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2021.116300","article-title":"Optimization of 1,4-bis(arylsulfonamido)naphthalene-N,N'-diacetic acids as inhibitors of Keap1-Nrf2 protein-protein interaction to suppress neuroinflammation","volume":"44","author":"Abed","year":"2021","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115302_bib22","doi-asserted-by":"crossref","first-page":"2736","DOI":"10.1021\/jm5000529","article-title":"Discovery of potent Keap1-Nrf2 protein-protein interaction inhibitor based on molecular binding determinants analysis","volume":"57","author":"Jiang","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115302_bib23","doi-asserted-by":"crossref","first-page":"6410","DOI":"10.1021\/acs.jmedchem.5b00185","article-title":"Structure\u2013activity and structure\u2013property relationship and exploratory in vivo evaluation of the nanomolar Keap1\u2013Nrf2 protein\u2013protein interaction inhibitor","volume":"58","author":"Jiang","year":"2015","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115302_bib24","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1177\/1060028013509232","article-title":"Dimethyl fumarate (Tecfidera): a new oral agent for multiple sclerosis","volume":"47","author":"Venci","year":"2013","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ejmech.2023.115302_bib25","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1185\/03007995.2013.863755","article-title":"Efficacy and safety of BG-12 (dimethyl fumarate) and other disease-modifying therapies for the treatment of relapsing-remitting multiple sclerosis: a systematic review and mixed treatment comparison","volume":"30","author":"Hutchinson","year":"2014","journal-title":"Curr. Med. Res. Opin."},{"key":"10.1016\/j.ejmech.2023.115302_bib26","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3109\/13506129.2012.751367","article-title":"Amelioration of Alzheimer's disease by neuroprotective effect of sulforaphane in animal model","volume":"20","author":"Kim","year":"2013","journal-title":"Amyloid"},{"key":"10.1016\/j.ejmech.2023.115302_bib27","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1016\/j.bmcl.2015.04.019","article-title":"Non-electrophilic modulators of the canonical Keap1\/Nrf2 pathway","volume":"25","author":"Richardson","year":"2015","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115302_bib28","doi-asserted-by":"crossref","first-page":"3039","DOI":"10.1016\/j.bmcl.2013.03.013","article-title":"Discovery of a small-molecule inhibitor and cellular probe of Keap1-Nrf2 protein-protein interaction","volume":"23","author":"Hu","year":"2013","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115302_bib29","doi-asserted-by":"crossref","first-page":"8029","DOI":"10.1021\/acs.jmedchem.8b01133","article-title":"Replacement of a naphthalene scaffold in kelch-like ECH-associated protein 1 (KEAP1)\/Nuclear factor (Erythroid-derived 2)-like 2 (NRF2) inhibitors","volume":"61","author":"Richardson","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115302_bib30","doi-asserted-by":"crossref","first-page":"6547","DOI":"10.1021\/acs.jmedchem.9b01074","article-title":"Isoquinoline kelch-like ECH-associated protein 1-nuclear factor (Erythroid-Derived 2)-like 2 (KEAP1-NRF2) inhibitors with high metabolic stability","volume":"63","author":"Lazzara","year":"2020","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115302_bib31","doi-asserted-by":"crossref","first-page":"3991","DOI":"10.1021\/acs.jmedchem.6b00228","article-title":"Monoacidic inhibitors of the Kelch-like ECH-associated protein 1: nuclear factor erythroid 2-related factor 2 (KEAP1:NRF2) protein\u2013protein interaction with high cell potency identified by fragment-based discovery","volume":"59","author":"Davies","year":"2016","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115302_bib32","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1021\/jm4017174","article-title":"Rapid identification of Keap1\u2013Nrf2 small-molecule inhibitors through structure-based virtual screening and Hit-based substructure search","volume":"57","author":"Zhuang","year":"2014","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115302_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2020.112734","article-title":"Discovery of 2-oxy-2-phenylacetic acid substituted naphthalene sulfonamide derivatives as potent KEAP1-NRF2 protein-protein interaction inhibitors for inflammatory conditions","volume":"207","author":"Lu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115302_bib34","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2020.115343","article-title":"Discovery of disubstituted xylylene derivatives as small molecule direct inhibitors of Keap1-Nrf2 protein-protein interaction","volume":"28","author":"Abed","year":"2020","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115302_bib35","doi-asserted-by":"crossref","first-page":"8029","DOI":"10.1021\/acs.jmedchem.8b01133","article-title":"Replacement of a naphthalene scaffold in kelch-like ECH-associated protein 1 (KEAP1)\/Nuclear factor (Erythroid-derived 2)-like 2 (NRF2) inhibitors","volume":"61","author":"Richardson","year":"2018","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115302_bib36","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejmech.2022.114380","article-title":"Structure-activity relationships of 1,4-bis(arylsulfonamido)-benzene or naphthalene-N,N'-diacetic acids with varying C2-substituents as inhibitors of Keap1-Nrf2 protein-protein interaction","volume":"237","author":"Lee","year":"2022","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115302_bib37","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1007\/s10822-014-9799-y","article-title":"Investigation of the intermolecular recognition mechanism between the E3 ubiquitin ligase Keap1 and substrate based on multiple substrates analysis","volume":"28","author":"Jiang","year":"2014","journal-title":"J. Comput. Aided Mol. Des."},{"key":"10.1016\/j.ejmech.2023.115302_bib38","doi-asserted-by":"crossref","first-page":"7380","DOI":"10.1021\/acs.jmedchem.2c00457","article-title":"Phenyl bis-sulfonamide keap1-nrf2 protein-protein interaction inhibitors with an alternative binding mode","volume":"65","author":"Georgakopoulos","year":"2022","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejmech.2023.115302_bib39","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/adsc.200600469","article-title":"Formation of arenes via diallylarenes: strategic utilization of suzuki\u2013miyaura cross\u2010coupling, claisen rearrangement and ring\u2010closing metathesis","volume":"349","author":"Kotha","year":"2007","journal-title":"Adv. Synth. Catal."},{"key":"10.1016\/j.ejmech.2023.115302_bib40","doi-asserted-by":"crossref","first-page":"6445","DOI":"10.1021\/jo101137r","article-title":"Synthesis of dibenzazepinones by palladium-catalyzed intramolecular arylation of o-(2\u2032-bromophenyl) anilide enolates","volume":"75","author":"Pan","year":"2010","journal-title":"J. Org. Chem."},{"key":"10.1016\/j.ejmech.2023.115302_bib41","doi-asserted-by":"crossref","first-page":"7138","DOI":"10.1039\/C6CC03106D","article-title":"Double C\u2013H amination by consecutive SET oxidations","volume":"52","author":"Evoniuk","year":"2016","journal-title":"Chem. Commun."},{"key":"10.1016\/j.ejmech.2023.115302_bib42","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1016\/j.bmcl.2016.10.083","article-title":"Synthesis of Keap1-phosphorylated p62 and Keap1-Nrf2 protein-protein interaction inhibitors and their inhibitory activity","volume":"26","author":"Yasuda","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2023.115302_bib43","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1177\/2472555220935816","article-title":"Development of a homogeneous time-resolved fluorescence resonance energy transfer (TR-FRET) assay for the inhibition of keap1-nrf2 protein-protein interaction","volume":"26","author":"Lee","year":"2021","journal-title":"SLAS Discov"},{"key":"10.1016\/j.ejmech.2023.115302_bib44","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1177\/1087057111430124","article-title":"Optimization of fluorescently labeled Nrf2 peptide probes and the development of a fluorescence polarization assay for the discovery of inhibitors of Keap1-Nrf2 interaction","volume":"17","author":"Inoyama","year":"2012","journal-title":"J. Biomol. Screen"}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423002684?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523423002684?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T06:04:37Z","timestamp":1777529077000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523423002684"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":44,"alternative-id":["S0223523423002684"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115302","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimization of the C2 substituents on the 1,4-bis(arylsulfonamido)naphthalene-N,N\u2032-diacetic acid scaffold for better inhibition of Keap1-Nrf2 protein-protein interaction","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2023.115302","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"115302"}}